Parathyroid hormone oxidation in chronic kidney disease: clinical relevance?
- 1 May 2021
- journal article
- editorial
- Published by Elsevier BV in Kidney International
- Vol. 99 (5), 1070-1072
- https://doi.org/10.1016/j.kint.2021.01.019
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Non-oxidized parathyroid hormone (PTH) measured by current method is not superior to total PTH in assessing bone turnover in chronic kidney diseaseKidney International, 2021
- Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2018
- Oxidation of PTH: in vivo feature or effect of preanalytical conditions?cclm, 2017
- Emerging role of post-translational modifications in chronic kidney disease and cardiovascular diseaseNephrology Dialysis Transplantation, 2015
- Modeling of Oxidized PTH (oxPTH) and Non-oxidized PTH (n-oxPTH) Receptor Binding and Relationship of Oxidized to Non-Oxidized PTH in Children with Chronic Renal Failure, Adult Patients on Hemodialysis and Kidney Transplant RecipientsKidney and Blood Pressure Research, 2013
- Measuring Parathyroid Hormone (PTH) in Patients with Oxidative Stress – Do We Need a Fourth Generation Parathyroid Hormone Assay?PLOS ONE, 2012
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996
- Effects of oxidation of human parathyroid hormone on its biological activity in continuously infused, thyroparathyroidectomized ratsJournal of Bone and Mineral Research, 1988
- Absence of Biological Effects of Oxidized Parathyroid Hormone-(1–3 4) in Dogs and Rats*Endocrinology, 1984